PRECLINICAL PHARMACOLOGY OF A NEW SEROTONERGIC RECEPTOR ANTAGONIST, LY281067

被引：0
|
作者：
COHEN, ML
FULLER, RW
KURZ, KD
PARLI, CJ
MASON, NR
MEYERS, DB
SMALLWOOD, JK
TOOMEY, RE
机构：
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1988年 / 244卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：106 / 112
页数：7
相关论文
共 50 条
  • [1] 5-HYDROXYTRYPTAMINE-2 RECEPTOR ANTAGONIST ACTIVITY OF THE ACID METABOLITE (1-ISOPROPYL DIHYDROLYSERGIC ACID) OF THE ERGOLINE ESTER, SERGOLEXOLE (LY281067)
    COHEN, ML
    PARLI, CJ
    FULLER, RW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1989, 251 (03): : 1006 - 1011
  • [2] PRECLINICAL STUDIES ON LY237733, A POTENT AND SELECTIVE SEROTONERGIC ANTAGONIST
    FOREMAN, MM
    FULLER, RW
    NELSON, DL
    CALLIGARO, DO
    KURZ, KD
    MISNER, JW
    GARBRECHT, WL
    PARLI, CJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 260 (01): : 51 - 57
  • [3] Preclinical pharmacology of R121919, a CRFI receptor antagonist
    Langlois, X
    Jurzak, M
    Leysen, JE
    Ashton, D
    Meert, T
    Grigoriadis, DE
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U135 - U135
  • [4] Preclinical pharmacology of bilastine, a new selective histamine H 1 receptor antagonist: Receptor selectivity and in Vitro antihistaminic activity
    Corcóstegui R.
    Labeaga L.
    Innerárity A.
    Berisa A.
    Orjales A.
    Drugs in R & D, 2005, 6 (6) : 371 - 384
  • [5] Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist
    Rogawski, M. A.
    Hanada, T.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 : 19 - 24
  • [6] DISCOVERY AND CHARACTERIZATION OF A NOVEL AMPA RECEPTOR ANTAGONIST, LY215490 - IN-VIVO PHARMACOLOGY
    SCHOEPP, DD
    ORNSTEIN, PL
    LEANDER, JD
    LODGE, D
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S282 - S282
  • [7] DISCOVERY AND CHARACTERIZATION OF A NOVEL AMPA RECEPTOR ANTAGONIST, LY215490 - IN-VITRO PHARMACOLOGY
    ORNSTEIN, PL
    SCHOEPP, DD
    LODGE, D
    ZIMMERMAN, D
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S282 - S282
  • [8] PRECLINICAL PHARMACOLOGY OF FLUOXETINE, A SEROTONERGIC DRUG FOR WEIGHT-LOSS
    YEN, TT
    FULLER, RW
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (01): : 177 - 180
  • [9] Synthesis and receptor pharmacology of hydia; a new group II mGlu receptor antagonist
    Adam, G
    Hennig, M
    Kolczewski, S
    Ohresser, S
    Wichmann, J
    Woltering, T
    Mutel, V
    NEUROPHARMACOLOGY, 1999, 38 (10) : A1 - A1
  • [10] Preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist
    Torphy, T.J.
    Faiferman, I.
    Gleason, J.G.
    Hall, R.F.
    Lewis, M.A.
    Broom, C.
    Helfrich, H.M.
    Newton, J.F.
    Hay, D.W.P.
    Annals of the New York Academy of Sciences, 1991, 629
12345